• Je něco špatně v tomto záznamu ?

Molecular-Level Control of Ciclopirox Olamine Release from Poly(ethylene oxide)-Based Mucoadhesive Buccal Films: Exploration of Structure-Property Relationships with Solid-State NMR

M. Urbanova, M. Gajdosova, M. Steinhart, D. Vetchy, J. Brus,

. 2016 ; 13 (5) : 1551-1563. [pub] 20160405

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18017320

Grantová podpora
NT14477 MZ0 CEP - Centrální evidence projektů

Mucoadhesive buccal films (MBFs) provide an innovative way to facilitate the efficient site-specific delivery of active compounds while simultaneously separating the lesions from the environment of the oral cavity. The structural diversity of these complex multicomponent and mostly multiphase systems as well as an experimental strategy for their structural characterization at molecular scale with atomic resolution were demonstrated using MBFs of ciclopirox olamine (CPX) in a poly(ethylene oxide) (PEO) matrix as a case study. A detailed description of each component of the CPX/PEO films was followed by an analysis of the relationships between each component and the physicochemical properties of the MBFs. Two distinct MBFs were identified by solid-state NMR spectroscopy: (i) at low API (active pharmaceutical ingredient) loading, a nanoheterogeneous solid solution of CPX molecularly dispersed in an amorphous PEO matrix was created; and (ii) at high API loading, a pseudoco-crystalline system containing CPX-2-aminoethanol nanocrystals incorporated into the interlamellar space of a crystalline PEO matrix was revealed. These structural differences were found to be closely related to the mechanical and physicochemical properties of the prepared MBFs. At low API loading, the polymer chains of PEO provided sufficient quantities of binding sites to stabilize the CPX that was molecularly dispersed in the highly amorphous semiflexible polymer matrix. Consequently, the resulting MBFs were soft, with low tensile strength, plasticity, and swelling index, supporting rapid drug release. At high CPX content, however, the active compounds and the polymer chains simultaneously cocrystallized, leaving the CPX to form nanocrystals grown directly inside the spherulites of PEO. Interfacial polymer-drug interactions were thus responsible not only for the considerably enhanced plasticity of the system but also for the exclusive crystallization of CPX in the thermodynamically most stable polymorphic form, Form I, which exhibited reduced dissolution kinetics. The bioavailability of CPX olamine formulated as PEO-based MBFs can thus be effectively controlled by inducing the complete dispersion and/or microsegregation and nanocrystallization of CPX olamine in the polymer matrix. Solid-state NMR spectroscopy is an efficient tool for exploring structure-property relationships in these complex pharmaceutical solids.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017320
003      
CZ-PrNML
005      
20190516145627.0
007      
ta
008      
180515s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.molpharmaceut.6b00035 $2 doi
035    __
$a (PubMed)27019088
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Urbanova, Martina $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic , Heyrovsky sq. 2, 162 06 Prague 6, Czech Republic.
245    10
$a Molecular-Level Control of Ciclopirox Olamine Release from Poly(ethylene oxide)-Based Mucoadhesive Buccal Films: Exploration of Structure-Property Relationships with Solid-State NMR / $c M. Urbanova, M. Gajdosova, M. Steinhart, D. Vetchy, J. Brus,
520    9_
$a Mucoadhesive buccal films (MBFs) provide an innovative way to facilitate the efficient site-specific delivery of active compounds while simultaneously separating the lesions from the environment of the oral cavity. The structural diversity of these complex multicomponent and mostly multiphase systems as well as an experimental strategy for their structural characterization at molecular scale with atomic resolution were demonstrated using MBFs of ciclopirox olamine (CPX) in a poly(ethylene oxide) (PEO) matrix as a case study. A detailed description of each component of the CPX/PEO films was followed by an analysis of the relationships between each component and the physicochemical properties of the MBFs. Two distinct MBFs were identified by solid-state NMR spectroscopy: (i) at low API (active pharmaceutical ingredient) loading, a nanoheterogeneous solid solution of CPX molecularly dispersed in an amorphous PEO matrix was created; and (ii) at high API loading, a pseudoco-crystalline system containing CPX-2-aminoethanol nanocrystals incorporated into the interlamellar space of a crystalline PEO matrix was revealed. These structural differences were found to be closely related to the mechanical and physicochemical properties of the prepared MBFs. At low API loading, the polymer chains of PEO provided sufficient quantities of binding sites to stabilize the CPX that was molecularly dispersed in the highly amorphous semiflexible polymer matrix. Consequently, the resulting MBFs were soft, with low tensile strength, plasticity, and swelling index, supporting rapid drug release. At high CPX content, however, the active compounds and the polymer chains simultaneously cocrystallized, leaving the CPX to form nanocrystals grown directly inside the spherulites of PEO. Interfacial polymer-drug interactions were thus responsible not only for the considerably enhanced plasticity of the system but also for the exclusive crystallization of CPX in the thermodynamically most stable polymorphic form, Form I, which exhibited reduced dissolution kinetics. The bioavailability of CPX olamine formulated as PEO-based MBFs can thus be effectively controlled by inducing the complete dispersion and/or microsegregation and nanocrystallization of CPX olamine in the polymer matrix. Solid-state NMR spectroscopy is an efficient tool for exploring structure-property relationships in these complex pharmaceutical solids.
650    _2
$a adheziva $x chemie $x metabolismus $7 D000269
650    _2
$a biologická dostupnost $7 D001682
650    _2
$a chemie farmaceutická $x metody $7 D002626
650    _2
$a krystalizace $x metody $7 D003460
650    _2
$a uvolňování léčiv $x fyziologie $7 D065546
650    _2
$a ethylenoxid $x chemie $7 D005027
650    _2
$a magnetická rezonanční spektroskopie $x metody $7 D009682
650    _2
$a ústní sliznice $x metabolismus $7 D009061
650    _2
$a nanočástice $x chemie $7 D053758
650    _2
$a orální absorpce $x fyziologie $7 D065568
650    _2
$a polyethylenglykoly $x chemie $x metabolismus $7 D011092
650    _2
$a polymery $x chemie $7 D011108
650    _2
$a pyridony $x chemie $7 D011728
650    _2
$a rozpustnost $7 D012995
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Gajdošová, Markéta $u Veterinary and Pharmaceutical University , Faculty of Pharmacy, Department of Pharmaceutics, Palacky Street 1946/1, 612 42 Brno, Czech Republic. $7 ola20191054731
700    1_
$a Steinhart, Miloš, $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic , Heyrovsky sq. 2, 162 06 Prague 6, Czech Republic. $d 1955- $7 ola2002159208
700    1_
$a Vetchý, David, $u Veterinary and Pharmaceutical University , Faculty of Pharmacy, Department of Pharmaceutics, Palacky Street 1946/1, 612 42 Brno, Czech Republic. $d 1972- $7 mzk2006368163
700    1_
$a Brus, Jiří, $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic , Heyrovsky sq. 2, 162 06 Prague 6, Czech Republic. $d 1970- $7 jo2011640489
773    0_
$w MED00008279 $t Molecular pharmaceutics $x 1543-8392 $g Roč. 13, č. 5 (2016), s. 1551-1563
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27019088 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20190516145734 $b ABA008
999    __
$a ok $b bmc $g 1300944 $s 1014160
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 13 $c 5 $d 1551-1563 $e 20160405 $i 1543-8392 $m Molecular pharmaceutics $n Mol Pharm $x MED00008279
GRA    __
$a NT14477 $p MZ0
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...